Press Releases
Letter to President Biden & Leaders of State Public Health Departments: Prioritizing COVID-19 Vaccines for Patients With Cancer and Survivors of Cancer
February 16, 2021 President Joseph R. Biden, Jr.The White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr…
Convenient Spit Test Helps Women Assess Cancer Risk From the Comfort of Their Own Home
First-of-its-kind clinical trial validates remote genetic counseling (New York) June 01, 2020 – Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who…
Ovarian Cancer Community Applauds Congress for Providing $35 million in Ovarian Cancer Research Funding at the Department of Defense in FY 2020 Spending Bill
WASHINGTON, D.C…
Leading ovarian cancer organization announces 2017 honorees
Largest private funder of ovarian cancer research recognizes top researchers and community leaders NEW YORK — Today, Ovarian Cancer Research Alliance (OCRFA), the nation’s leading ovarian cancer research, advocacy and patient support…
OCRFA applauds FDA’s statement on ovarian cancer screening test
On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated…
Super Saturday Events Raise Close to $3.5 Million for OCRFA
Donna Karan, Kelly Ripa and Gabby Karan de Felice hosted Ovarian Cancer Research Alliance’s (OCRFA) 19th annual Super Saturday NY…
Newk's Unites 100 Restaurants to Raise $100,000 for Ovarian Cancer Research
Foodie Fast-Casual Brand Reaches Halfway Point in Its 200-Unit Growth Plan JACKSON, Miss…
Newk's Raises more than $110,000 for OCRFA
When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis…
Zubik v. Burwell & the Supreme Court
FOR IMMEDIATE RELEASE May 17, 2016 Lisa Mauti lmauti@ocrfa.org 202-517-6410 Supreme Court Returns Zubik v…
Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards
May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-‐affiliated scientists…
Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research
Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A…
OCRFA Statement on Results of GOG 252
April 11, 2016 – Many members of the ovarian cancer community have been concerned about the results of GOG 252 clinical trial, which were released last month at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer…